Poseida Therapeutics, Inc. (PSTX) Misses Q4 EPS by 56c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Sales and marketing: 1.22M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Sales and marketing: 1.22M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q4 EPS of ($0.39), $0.56 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $10.05 million versus the consensus estimate of $61.69 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
